95 related articles for article (PubMed ID: 9141212)
1. Romurtide, a synthetic muramyl dipeptide derivative, promotes megakaryocytopoiesis through stimulation of cytokine production in nonhuman primates with myelosuppression.
Namba K; Yamamura E; Nitanai H; Otani T; Azuma I
Vaccine; 1997 Mar; 15(4):405-13. PubMed ID: 9141212
[TBL] [Abstract][Full Text] [Related]
2. Stimulatory effect of romurtide on hematopoiesis in monkeys.
Nakajima R; Yshida Y; Akahane K; Sekiguchi M; Osada Y
Arzneimittelforschung; 1991 Jan; 41(1):60-5. PubMed ID: 2049113
[TBL] [Abstract][Full Text] [Related]
3. Romurtide, a synthetic muramyl dipeptide derivative, accelerates peripheral platelet recovery in nonhuman primate chemotherapy model.
Namba K; Nitanai H; Otani T; Azuma I
Vaccine; 1996 Oct; 14(14):1322-6. PubMed ID: 9004440
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of platelet recovery in X-irradiated guinea pigs by romurtide, a synthetic muramyl dipeptide derivative.
Namba K; Otani T; Osada Y
Blood; 1994 May; 83(9):2480-8. PubMed ID: 8167336
[TBL] [Abstract][Full Text] [Related]
5. Differences in interleukin 1 (IL-1), IL-6, tumor necrosis factor and IL-1 receptor antagonist production by human monocytes stimulated with muramyl dipeptide (MDP) and its stearoyl derivative, romurtide.
Suzuki K; Torii K; Hida S; Hayashi H; Hiyama Y; Oomoto Y; Takii T; Chiba T; Onozaki K
Immunopharmacology; 1994; 28(1):31-8. PubMed ID: 7928300
[TBL] [Abstract][Full Text] [Related]
6. Oral application of romurtide, a synthetic muramyl dipeptide derivative, stimulates nonspecific resistance to microbial infections and hematopoiesis in mice.
Namba K; Nakajima R; Otani T; Azuma I
Vaccine; 1996 Aug; 14(12):1149-53. PubMed ID: 8911012
[TBL] [Abstract][Full Text] [Related]
7. Review: inducer of cytokines in vivo: overview of field and romurtide experience.
Azuma I
Int J Immunopharmacol; 1992 Apr; 14(3):487-96. PubMed ID: 1618600
[TBL] [Abstract][Full Text] [Related]
8. Restorative effect of romurtide for thrombocytopenia associated with intensive anticancer drug treatment and/or irradiation in patients with gastrointestinal cancer.
Yano K; Matsuoka H; Seo Y; Kounoe S; Saito T; Tomoda H
Anticancer Res; 1995; 15(6B):2883-7. PubMed ID: 8669883
[TBL] [Abstract][Full Text] [Related]
9. Induction of colony-stimulating factor and stimulation of stem cell proliferation by injection of muroctasin.
Yamaguchi F; Akasaki M; Tsukada W
Arzneimittelforschung; 1988 Jul; 38(7A):980-3. PubMed ID: 3263869
[TBL] [Abstract][Full Text] [Related]
10. Modulation of myelopoiesis in vivo by synthetic adjuvant-active muramyl peptides: induction of colony-stimulating activity and stimulation of stem cell proliferation.
Galelli A; Chedid L
Infect Immun; 1983 Dec; 42(3):1081-5. PubMed ID: 6605930
[TBL] [Abstract][Full Text] [Related]
11. Production of interleukin-6 from macrophages by MDP-Lys (L 18), romurtide.
Shimoda K; Okamura S; Harada N; Omori F; Niho Y
Res Commun Chem Pathol Pharmacol; 1990 Dec; 70(3):289-96. PubMed ID: 2093210
[TBL] [Abstract][Full Text] [Related]
12. Differential effect of erythropoietin and GM-CSF on megakaryocytopoiesis from primitive bone marrow cells in serum-free conditions.
Cardier JE; Erickson-Miller CL; Murphy MJ
Stem Cells; 1997; 15(4):286-90. PubMed ID: 9253112
[TBL] [Abstract][Full Text] [Related]
13. Recombinant human granulocyte-macrophage colony-stimulating factor promotes megakaryocyte maturation in nonhuman primates.
Stahl CP; Winton EF; Monroe MC; Holman RC; Zelasky M; Liehl E; Myers LA; McClure H; Anderson D; Evatt BL
Exp Hematol; 1991 Sep; 19(8):810-6. PubMed ID: 1868895
[TBL] [Abstract][Full Text] [Related]
14. Potentiation of host defense mechanism against infection by a cytokine inducer, an acyl-MDP derivative, MDP-Lys(L18) (romurtide) in mice and humans.
Azuma I; Otani T
Med Res Rev; 1994 Jul; 14(4):401-14. PubMed ID: 8084203
[No Abstract] [Full Text] [Related]
15. The effect of cytokines on the ploidy of megakaryocytes.
Teramura M; Mizoguchi H
Int J Cell Cloning; 1990 Jul; 8(4):245-52. PubMed ID: 2205662
[TBL] [Abstract][Full Text] [Related]
16. Synergistic effect of romurtide with ampicillin against pneumococcal pneumonia in mice.
Nakajima R; Namba K; Ishida Y; Katsuma E; Otani T; Osada Y
Chemotherapy; 1992; 38(4):238-50. PubMed ID: 1473363
[TBL] [Abstract][Full Text] [Related]
17. Development of the cytokine inducer romurtide: experimental studies and clinical application.
Azuma I
Trends Pharmacol Sci; 1992 Dec; 13(12):425-8. PubMed ID: 1293866
[No Abstract] [Full Text] [Related]
18. In vitro and in vivo effects of MDP-Lys(L18) on mouse megakaryocyte progenitor cells (CFU-Meg).
Komiya I; Kuriya S; Akahane K; Nomura T
Exp Hematol; 1992 May; 20(4):517-22. PubMed ID: 1568468
[TBL] [Abstract][Full Text] [Related]
19. Effects of thrombocytopoiesis-stimulating factor on terminal cytoplasmic maturation of human megakaryocytes.
Straneva JE; Briddell RA; McDonald TP; Yang HH; Hoffman R
Exp Hematol; 1989 Dec; 17(11):1122-7. PubMed ID: 2684680
[TBL] [Abstract][Full Text] [Related]
20. Intrapleural therapy with MDP-Lys (L18), a synthetic derivative of muramyl dipeptide, against malignant pleurisy associated with lung cancer.
Yanagawa H; Haku T; Takeuchi E; Suzuki Y; Nokihara H; Sone S
Lung Cancer; 2000 Feb; 27(2):67-73. PubMed ID: 10688489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
